MaxCyte, Inc.
MaxCyte, Inc.（MXCT）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · MXCT · 截至 2026年6月8日
活动摘要
买入笔数
5
P-Purchase only
卖出笔数
2
近12个月
买卖比
2.50
Buy/Sell (by trades)
整体情绪
MaxCyte, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
MXCT 季度内部人买卖趋势
MXCT 内幕交易卖出 · MXCT 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · MXCT CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
MXCT 高管卖出股份 · MXCT 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Apr 15, 2026 | Ahuja Parmeet CFO | Award | 187,500 | — | Form 4 |
| Mar 27, 2026 | Masoud Maher President and CEO · Director | Award | 300,000 | — | Form 4 |
| Mar 17, 2026 | Swirsky Douglas J CHIEF FINANCIAL OFFICER | Sale | 10,142 | $8K | Form 4 |
| Jun 25, 2025 | Hemrajani Rekha Director | Sale | 10,684 | $22K | Form 4 |
| Aug 13, 2025 | Swirsky Douglas J CHIEF FINANCIAL OFFICER | Purchase | 50,000 | $65K | Form 4 |
| Aug 13, 2025 | Masoud Maher President and CEO · Director | Purchase | 75,000 | $103K | Form 4 |
| Aug 13, 2025 | Erck Stanley C Director | Purchase | 100,000 | $137K | Form 4 |
| Aug 13, 2025 | DOUGLAS RICHARD Director | Purchase | 80,000 | $111K | Form 4 |
| Aug 13, 2025 | Brooke William W Director | Purchase | 50,000 | $65K | Form 4 |
| Jun 18, 2025 | Johnston John Joseph Director | Award | 29,210 | — | Form 4 |
| Jun 18, 2025 | Hemrajani Rekha Director | Award | 29,210 | — | Form 4 |
| Jun 18, 2025 | Erck Stanley C Director | Award | 29,210 | — | Form 4 |
| Jun 18, 2025 | DOUGLAS RICHARD Director | Award | 29,210 | — | Form 4 |
| Jun 18, 2025 | Collins Cynthia Director | Award | 29,210 | — | Form 4 |
| Jun 18, 2025 | Brooke William W Director | Award | 29,210 | — | Form 4 |
| Jun 18, 2025 | BALTHROP PATRICK J Director | Award | 29,210 | — | Form 4 |
| Jun 18, 2025 | Al-Wakeel Yasir B. Director | Award | 29,210 | — | Form 4 |
| Mar 18, 2025 | Soleymannezhad Ali Chief Commercial Officer | Sale | 1,211 | $4K | Form 4 |
| Mar 18, 2025 | Sandoval David I. GENERAL COUNSEL | Sale | 353 | $1K | Form 4 |
| Mar 18, 2025 | Swirsky Douglas J CHIEF FINANCIAL OFFICER | Sale | 6,939 | $22K | Form 4 |
| Mar 14, 2025 | Soleymannezhad Ali Chief Commercial Officer | Award | 34,625 | — | Form 4 |
| Mar 14, 2025 | Sandoval David I. GENERAL COUNSEL | Award | 23,125 | — | Form 4 |
| Mar 14, 2025 | Swirsky Douglas J CHIEF FINANCIAL OFFICER | Award | 37,500 | — | Form 4 |
| Jan 27, 2025 | Johnston John Joseph Director | Option | 3,000 | $9K | Form 4 |
| Jan 27, 2025 | Johnston John Joseph Director | Sale | 3,000 | $14K | Form 4 |
Swirsky Douglas J
CHIEF FINANCIAL OFFICER
日期
Aug 13
股数
50,000
均价
$1.29
总金额
$65K
Masoud Maher
President and CEO · Director
日期
Aug 13
股数
75,000
均价
$1.37
总金额
$103K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 MXCT 内幕交易
MXCT 内幕交易
MaxCyte, Inc.（MXCT）内幕交易数据来源于公司内部人（包括Masoud Maher (President and CEO · Director), Swirsky Douglas J (CHIEF FINANCIAL OFFICER), Hemrajani Rekha (Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。MXCT内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看MaxCyte, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
MXCT 内幕交易 · 5个问题MaxCyte, Inc.（MXCT）的内部人包括高管和董事，如Masoud Maher (President and CEO · Director), Swirsky Douglas J (CHIEF FINANCIAL OFFICER), Hemrajani Rekha (Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026